213 related articles for article (PubMed ID: 19553667)
1. A progesterone receptor co-activator (JDP2) mediates activity through interaction with residues in the carboxyl-terminal extension of the DNA binding domain.
Hill KK; Roemer SC; Jones DN; Churchill ME; Edwards DP
J Biol Chem; 2009 Sep; 284(36):24415-24. PubMed ID: 19553667
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the amino-terminal transcription activation domain of progesterone receptor by a cofactor-induced protein folding mechanism.
Wardell SE; Kwok SC; Sherman L; Hodges RS; Edwards DP
Mol Cell Biol; 2005 Oct; 25(20):8792-808. PubMed ID: 16199860
[TBL] [Abstract][Full Text] [Related]
3. Jun dimerization protein 2 functions as a progesterone receptor N-terminal domain coactivator.
Wardell SE; Boonyaratanakornkit V; Adelman JS; Aronheim A; Edwards DP
Mol Cell Biol; 2002 Aug; 22(15):5451-66. PubMed ID: 12101239
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of high-mobility group protein B enhancement of progesterone receptor sequence-specific DNA binding.
Roemer SC; Adelman J; Churchill ME; Edwards DP
Nucleic Acids Res; 2008 Jun; 36(11):3655-66. PubMed ID: 18474528
[TBL] [Abstract][Full Text] [Related]
5. Progesterone receptor interacting coregulatory proteins and cross talk with cell signaling pathways.
Edwards DP; Wardell SE; Boonyaratanakornkit V
J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):173-86. PubMed ID: 12650714
[TBL] [Abstract][Full Text] [Related]
6. Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo.
Tetel MJ; Giangrande PH; Leonhardt SA; McDonnell DP; Edwards DP
Mol Endocrinol; 1999 Jun; 13(6):910-24. PubMed ID: 10379890
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the structurally dynamic N-terminal domain of progesterone receptor by protein-induced folding.
Kumar R; Moure CM; Khan SH; Callaway C; Grimm SL; Goswami D; Griffin PR; Edwards DP
J Biol Chem; 2013 Oct; 288(42):30285-30299. PubMed ID: 23995840
[TBL] [Abstract][Full Text] [Related]
8. Hinge and amino-terminal sequences contribute to solution dimerization of human progesterone receptor.
Tetel MJ; Jung S; Carbajo P; Ladtkow T; Skafar DF; Edwards DP
Mol Endocrinol; 1997 Jul; 11(8):1114-28. PubMed ID: 9212059
[TBL] [Abstract][Full Text] [Related]
9. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay.
Leonhardt SA; Altmann M; Edwards DP
Mol Endocrinol; 1998 Dec; 12(12):1914-30. PubMed ID: 9849965
[TBL] [Abstract][Full Text] [Related]
10. Selective interactions of Kruppel-like factor 9/basic transcription element-binding protein with progesterone receptor isoforms A and B determine transcriptional activity of progesterone-responsive genes in endometrial epithelial cells.
Zhang XL; Zhang D; Michel FJ; Blum JL; Simmen FA; Simmen RC
J Biol Chem; 2003 Jun; 278(24):21474-82. PubMed ID: 12672823
[TBL] [Abstract][Full Text] [Related]
11. Partial agonist activity of the progesterone receptor antagonist RU486 mediated by an amino-terminal domain coactivator and phosphorylation of serine400.
Wardell SE; Narayanan R; Weigel NL; Edwards DP
Mol Endocrinol; 2010 Feb; 24(2):335-45. PubMed ID: 20008003
[TBL] [Abstract][Full Text] [Related]
12. Partial oncogenic transformation of chicken embryo fibroblasts by Jun dimerization protein 2, a negative regulator of TRE- and CRE-dependent transcription.
Blazek E; Wasmer S; Kruse U; Aronheim A; Aoki M; Vogt PK
Oncogene; 2003 Apr; 22(14):2151-9. PubMed ID: 12687017
[TBL] [Abstract][Full Text] [Related]
13. Structure of the progesterone receptor-deoxyribonucleic acid complex: novel interactions required for binding to half-site response elements.
Roemer SC; Donham DC; Sherman L; Pon VH; Edwards DP; Churchill ME
Mol Endocrinol; 2006 Dec; 20(12):3042-52. PubMed ID: 16931575
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional analysis of domains of the progesterone receptor.
Hill KK; Roemer SC; Churchill ME; Edwards DP
Mol Cell Endocrinol; 2012 Jan; 348(2):418-29. PubMed ID: 21803119
[TBL] [Abstract][Full Text] [Related]
15. Mapping and characterization of the functional domains responsible for the differential activity of the A and B isoforms of the human progesterone receptor.
Giangrande PH; Pollio G; McDonnell DP
J Biol Chem; 1997 Dec; 272(52):32889-900. PubMed ID: 9407067
[TBL] [Abstract][Full Text] [Related]
16. Differential targeting of the stress mitogen-activated protein kinases to the c-Jun dimerization protein 2.
Katz S; Aronheim A
Biochem J; 2002 Dec; 368(Pt 3):939-45. PubMed ID: 12225289
[TBL] [Abstract][Full Text] [Related]
17. Characterization of unique DNA-binding and transcriptional-activation functions in the carboxyl-terminal extension of the zinc finger region in the human vitamin D receptor.
Hsieh JC; Whitfield GK; Oza AK; Dang HT; Price JN; Galligan MA; Jurutka PW; Thompson PD; Haussler CA; Haussler MR
Biochemistry; 1999 Dec; 38(49):16347-58. PubMed ID: 10587460
[TBL] [Abstract][Full Text] [Related]
18. Jun Dimerization Protein 2 Activates Mc2r Transcriptional Activity: Role of Phosphorylation and SUMOylation.
Wang CM; Wang RX; Liu R; Yang WH
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146118
[TBL] [Abstract][Full Text] [Related]
19. Functional properties of the N-terminal region of progesterone receptors and their mechanistic relationship to structure.
Takimoto GS; Tung L; Abdel-Hafiz H; Abel MG; Sartorius CA; Richer JK; Jacobsen BM; Bain DL; Horwitz KB
J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):209-19. PubMed ID: 12943706
[TBL] [Abstract][Full Text] [Related]
20. Sequence specific transcription factor, JDP2 interacts with histone and inhibits p300-mediated histone acetylation.
Pan J; Jin C; Murata T; Yokoyama KK
Nucleic Acids Res Suppl; 2003; (3):305-6. PubMed ID: 14510502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
